Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cross Country Healthcare Inc gives Q3 2014 guidance; revenue guidance in line with analysts' estimates


Wednesday, 6 Aug 2014 09:00pm EDT 

Cross Country Healthcare Inc:Sees Q3 2014 revenues of between $187 mln - $192 mln.Sees Q3 2014 Adjusted EBITDA to be between 3.0 pct. - 3.5 pct.Q3 2014 revenue estimates of $182 mln and EBITDA of $4 mln - Thomson Reuters I/B/E/S. 

Company Quote

12.64
-0.04 -0.32%
4:00pm EDT